NCT06277154 2025-07-24MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaHRYZ Biotech Co.Phase 2 Recruiting148 enrolled
NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled